Literature DB >> 3218552

The recurrence of supratentorial meningiomas after surgery.

J W Beks1, H L de Windt.   

Abstract

A series of 113 consecutive patients underwent surgical treatment for a supratentorial meningioma between January 1955 and January 1975. There were 73 women and 40 men. There were 10 postoperative deaths (8.8%). The surgical procedure was graded according to Simpson's classification. 18 patients had a recurrence (17.5%). Women had a preponderance for recurrence. In our series the recurrence rate was 13 for women (17.8%) and 5 for men (12.5%). There was no correlation with the age of the patient or site of the tumour. The grade of initial surgery and the histology of the tumour were shown to be important.

Entities:  

Mesh:

Year:  1988        PMID: 3218552     DOI: 10.1007/bf01793074

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  D SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

2.  Role of radiation therapy in the management of meningioma.

Authors:  R J Carella; J Ransohoff; J Newall
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

Review 3.  Meningiomas: an update.

Authors:  D O Quest
Journal:  Neurosurgery       Date:  1978 Sep-Oct       Impact factor: 4.654

4.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  A B Adegbite; M I Khan; K W Paine; L K Tan
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

  4 in total
  11 in total

1.  Factors influencing meningioma recurrence rate.

Authors:  M Naumann; J Meixensberger
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

3.  WHO grade I meningiomas: classification-tree for prognostic factors of survival.

Authors:  Jean-Michel Lemée; Holger Joswig; Michele Da Broi; Marco Vincenzo Corniola; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2019-06-10       Impact factor: 3.042

Review 4.  Aberrant signaling pathways in meningiomas.

Authors:  Brian T Ragel; Randy L Jensen
Journal:  J Neurooncol       Date:  2010-09-14       Impact factor: 4.130

5.  Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.

Authors:  T W Dziuk; S Woo; E B Butler; J Thornby; R Grossman; W S Dennis; H Lu; L S Carpenter; J K Chiu
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

6.  Intracranial meningiomas: analysis of recurrence after surgical treatment.

Authors:  A Mahmood; N H Qureshi; G M Malik
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Linear accelerator-based radiosurgery in the management of skull base meningiomas.

Authors:  Chi-Cheng Chuang; Chen-Nen Chang; Ngan-Ming Tsang; Kuo-Chen Wei; Chen-Kan Tseng; Joseph Tung-Chien Chang; Ping-Ching Pai
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

8.  Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up.

Authors:  Faruk Ildan; Tahsin Erman; A Iskender Göçer; Metin Tuna; Hüseyin Bağdatoğlu; Erdal Cetinalp; Refik Burgut
Journal:  Skull Base       Date:  2007-05

9.  Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application.

Authors:  Cornelia Lerner; Ralf Ketter; Stefan Linsler; Wolfram Henn; Joachim Oertel; Steffi Urbschat
Journal:  Mol Cytogenet       Date:  2014-02-05       Impact factor: 2.009

10.  Molecular biological determinations of meningioma progression and recurrence.

Authors:  Stefan Linsler; Dennis Kraemer; Christina Driess; Joachim Oertel; Kai Kammers; Jörg Rahnenführer; Ralf Ketter; Steffi Urbschat
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.